As enclosed herewith.

Nukleus Office Solutions Limited CIN NO -L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work│ Website: www.nukleus.work│ Date: 29.08.2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400 001 Scrip Code: 544370 Sub.: Intimation under SEBI (Listing Obligation and Disclosure Requirement), 2015, - Outcome of Board Meeting. Dear Sir/Ma’am, The Board of Directors, inter alia, considered and approved the following matters: 1. Approval of Employee Stock Option Scheme The Board considered the recommendation of the Nomination and Remuneration Committee and approved the proposed NUKLEUS OFFICE SOLUTIONS LIMITED EMPLOYEE STOCK OPTION SCHEME – I 2026 (“ESOP Scheme”) of the Company, in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, subject to obtaining the approval of the shareholders and such other approvals as may be required under applicable laws. The ESOP Scheme is intended to attract, retain and motivate eligible employees and align their interests with the long-term growth and performance of the Company. Principal Terms of the ESOP Scheme: - The Board approved the broad terms and conditions of the proposed ESOP Scheme, inter alia, as follows: • Total number of Options proposed to be granted: 201,600 Employee Stock Options, each Option being convertible into one equity share of the Company, subject to the terms and conditions of the ESOP Scheme. • Category-wise allocation of Options: The Options proposed to be granted shall be allocated amongst eligible employees in accordance with the category-wise allocation approved/recommended by the NRC. • Vesting Period: The Options shall vest upon completion of one year from the date of Grant, subject to fulfilment of the applicable vesting conditions as specified under the ESOP Scheme. • Exercise Price / Pricing Mechanism: The Exercise Price shall be determined in accordance with the applicable provisions of law and the terms of the ESOP Scheme prevailing at the time of Grant of Options. • Exercise Period: The vested Options shall be exercisable within two years from the date of Grant, subject to the terms and conditions specified under the ESOP Scheme. Regd. Office: 1102, Barakhamba Tower, 22 Barakhamba Road, Connaught Place, New Delhi, Central Delhi- 110001, Delhi Corporate Office: Plot No 29, Sector -142, Noida, UP – 201305 Nukleus Office Solutions Limited CIN NO -L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work│ Website: www.nukleus.work│ • Vesting Conditions: Vesting of Options shall be subject to such conditions, including continued employment/service and performance-linked conditions, if any, as may be specified in the ESOP Scheme. • Maximum number of Options that may be granted to any eligible employee: As specified in the ESOP Scheme and subject to the applicable provisions of law. • Treatment of Options upon cessation of employment: The treatment of vested and unvested Options in case of resignation, retirement, death, permanent incapacity, termination or any other cessation of employment shall be governed by the provisions of the ESOP Scheme and applicable laws. • Other terms and conditions: All other terms and conditions relating to the Grant, Vesting and Exercise of Options, adjustment of Options, lapse/forfeiture, corporate actions and other matters shall be governed by the ESOP Scheme and applicable laws. Approval of Shareholders The Board further approved the proposal to seek the approval of the members of the Company by way of Special Resolution for implementation of the ESOP Scheme and authorized the convening of a General Meeting of the Company for this purpose. The draft Notice of the General Meeting, together with the Explanatory Statement pursuant to Section 102 of the Companies Act, 2013, was also approved by the Board. Authorisation The Board authorized Mr. Vinay Rathore, Company Secretary and Compliance Officer to take all necessary steps, make the requisite filings and submissions with the Registrar of Companies, Stock Exchange(s), SEBI, depositories and/or any other statutory or regulatory authority, as may be applicable, and to do all such acts, deeds and things as may be necessary to give effect to the aforesaid decisions. The meeting commenced at 07:00 P.M. and concluded at 07:24 P.M. This is for your information and records. Thanking You, For Nukleus Office Solutions Limited Vinay Rathore Membership No. 75848 (Company Secretary & Compliance Officer) Regd. Office: 1102, Barakhamba Tower, 22 Barakhamba Road, Connaught Place, New Delhi, Central Delhi- 110001, Delhi Corporate Office: Plot No 29, Sector -142, Noida, UP – 201305